Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
Oncology
|
March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor
Karin Oechsle, Anja Lorch, Friedemann Honecker, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
March 17, 2025
Dying in hospital: a retrospective medical record analysis on care in the dying phase in intensive care units and general wards
Sophie Meesters, Aneta Schieferdecker, Sukhvir Kaur, et al.
Anti-Cancer Drugs
|
February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors
Karin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
Journal of Pain and Symptom Management
|
August 25, 2024
Death Anxiety in Patients With Advanced Cancer and Their Family Caregivers
Charlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Contemporary Clinical Trials
|
December 10, 2013
Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol
Wiebke Jensen, Karin Oechsle, Hans Jörg Baumann, et al.
Cancer
|
May 17, 2002
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma
Christian Kollmannsberger, Karin Oechsle, Bernhard M Dohmen, et al.
BMC Palliative Care
|
March 2, 2016
Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study
Anna Creutzfeldt, Anna Suling, Karin Oechsle, et al.
European Urology
|
June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors
Karin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
Thrombosis Research
|
July 25, 2015
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy
Christine Jacobsen, Karin Oechsle, Jessica Hauschild, et al.
Scientific Reports
|
July 2, 2025
A qualitative interview study on psycho-oncologists' experiences with patient deaths in Germany
Svenja Wandke, Lisa Brandes, Mareike Rutenkröger, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
Oncology
|
March 11, 2010
Patterns of relapse after chemotherapy in patients with high-risk non-seminomatous germ cell tumor
Karin Oechsle, Anja Lorch, Friedemann Honecker, et al.
International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care
|
March 17, 2025
Dying in hospital: a retrospective medical record analysis on care in the dying phase in intensive care units and general wards
Sophie Meesters, Aneta Schieferdecker, Sukhvir Kaur, et al.
Anti-Cancer Drugs
|
February 1, 2007
An open-label, multicenter phase II trial of capecitabine in patients with cisplatin-refractory or relapsed germ cell tumors
Karin Oechsle, Friedemann Honecker, Christian Kollmannsberger, et al.
Journal of Pain and Symptom Management
|
August 25, 2024
Death Anxiety in Patients With Advanced Cancer and Their Family Caregivers
Charlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Contemporary Clinical Trials
|
December 10, 2013
Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy--a study protocol
Wiebke Jensen, Karin Oechsle, Hans Jörg Baumann, et al.
Cancer
|
May 17, 2002
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma
Christian Kollmannsberger, Karin Oechsle, Bernhard M Dohmen, et al.
BMC Palliative Care
|
March 2, 2016
Integrating patient reported measures as predictive parameters into decisionmaking about palliative chemotherapy: a pilot study
Anna Creutzfeldt, Anna Suling, Karin Oechsle, et al.
European Urology
|
June 28, 2011
Long-term survival after treatment with gemcitabine and oxaliplatin with and without paclitaxel plus secondary surgery in patients with cisplatin-refractory and/or multiply relapsed germ cell tumors
Karin Oechsle, Christian Kollmannsberger, Friedemann Honecker, et al.
Thrombosis Research
|
July 25, 2015
Regulation of tissue factor in NT2 germ cell tumor cells by cisplatin chemotherapy
Christine Jacobsen, Karin Oechsle, Jessica Hauschild, et al.
Scientific Reports
|
July 2, 2025
A qualitative interview study on psycho-oncologists' experiences with patient deaths in Germany
Svenja Wandke, Lisa Brandes, Mareike Rutenkröger, et al.
Page
of 12